How Should We Evaluate Outcomes for Use of Biologics in the Knee?

Abstract

In recent years, the use of biologics for the primary treatment and augmentation of treatment in patients with knee pathology has increased substantially. Techniques and applications for biologic preparations such as platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) have been developed and refined to increase the healing response in bone, ligaments, cartilage, meniscal tissue, and other areas of the knee. Beginning with basic science and animal models, and finally proceeding to clinical human trials, the effect of biologics on clinical outcomes has been widely studied; however, many results have been inconclusive on their true effectiveness. The purpose of this article is to review current strategies for evaluating outcomes after biologic treatment and to propose new recommendations for assessing outcomes following the use of biologics in the knee. In addition, the importance of study design, current challenges, and future directions will be reviewed to describe the current standards for future studies to follow.

Keywords

outcomes - biologics - knee - platelet-rich plasma - mesenchymal stem cells

• References

• 1 Anz AW, Hackel JG, Nilssen EC, Andrews JR. Application of biologics in the treatment of the rotator cuff, meniscus, cartilage, and osteoarthritis. J Am Acad Orthop Surg 2014; 22 (2) 68-79
• 2 Braun HJ, Wasterlain AS, Dragoo JL. The use of PRP in ligament and meniscal healing. Sports Med Arthrosc 2013; 21 (4) 206-212
• 3 Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 2009; 37 (11) 2259-2272
• 4 Obremskey WT, Marotta JS, Yaszemski MJ, Churchill LR, Boden SD, Dirschl DR. Symposium. The introduction of biologics in orthopaedics: issues of cost, commercialism, and ethics. J Bone Joint Surg Am 2007; 89 (7) 1641-1649
• 5 Caplan AI, Correa D. PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs. J Orthop Res 2011; 29 (12) 1795-1803
• 6 Cesselli D, Beltrami AP, Rigo S , et al. Multipotent progenitor cells are present in human peripheral blood. Circ Res 2009; 104 (10) 1225-1234
• 7 Hung SC, Cheng H, Pan CY, Tsai MJ, Kao LS, Ma HL. In vitro differentiation of size-sieved stem cells into electrically active neural cells. Stem Cells 2002; 20 (6) 522-529
• 8 Delos D, Rodeo SA. Enhancing meniscal repair through biology: platelet-rich plasma as an alternative strategy. Instr Course Lect 2011; 60: 453-460
• 9 de Mos M, van der Windt AE, Jahr H , et al. Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med 2008; 36 (6) 1171-1178
• 10 Schnabel LV, Mohammed HO, Miller BJ , et al. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 2007; 25 (2) 230-240
• 11 Fukumoto T, Sperling JW, Sanyal A , et al. Combined effects of insulin-like growth factor-1 and transforming growth factor-beta1 on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthritis Cartilage 2003; 11 (1) 55-64
• 12 Ishida K, Kuroda R, Miwa M , et al. The regenerative effects of platelet-rich plasma on meniscal cells in vitro and its in vivo application with biodegradable gelatin hydrogel. Tissue Eng 2007; 13 (5) 1103-1112
• 13 Taylor MA, Norman TL, Clovis NB, Blaha JD. The response of rabbit patellar tendons after autologous blood injection. Med Sci Sports Exerc 2002; 34 (1) 70-73
• 14 Kajikawa Y, Morihara T, Sakamoto H , et al. Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing. J Cell Physiol 2008; 215 (3) 837-845
• 15 Wilke MM, Nydam DV, Nixon AJ. Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 2007; 25 (7) 913-925
• 16 Zellner J, Mueller M, Berner A , et al. Role of mesenchymal stem cells in tissue engineering of meniscus. J Biomed Mater Res A 2010; 94 (4) 1150-1161
• 17 Joshi SM, Mastrangelo AN, Magarian EM, Fleming BC, Murray MM. Collagen-platelet composite enhances biomechanical and histologic healing of the porcine anterior cruciate ligament. Am J Sports Med 2009; 37 (12) 2401-2410
• 18 Murray MM, Spindler KP, Devin C , et al. Use of a collagen-platelet rich plasma scaffold to stimulate healing of a central defect in the canine ACL. J Orthop Res 2006; 24 (4) 820-830
• 19 Hildebrand KA, Woo SL, Smith DW , et al. The effects of platelet-derived growth factor-BB on healing of the rabbit medial collateral ligament. An in vivo study. Am J Sports Med 1998; 26 (4) 549-554
• 20 Letson AK, Dahners LE. The effect of combinations of growth factors on ligament healing. Clin Orthop Relat Res 1994; (308) 207-212
• 21 Yoshioka T, Kanamori A, Washio T , et al. The effects of plasma rich in growth factors (PRGF-Endoret) on healing of medial collateral ligament of the knee. Knee Surg Sports Traumatol Arthrosc 2013; 21 (8) 1763-1769
• 22 Biercevicz AM, Miranda DL, Machan JT, Murray MM, Fleming BC. In Situ, noninvasive, T2*-weighted MRI-derived parameters predict ex vivo structural properties of an anterior cruciate ligament reconstruction or bioenhanced primary repair in a porcine model. Am J Sports Med 2013; 41 (3) 560-566
• 23 Lysholm J, Gillquist J. Evaluation of knee ligament surgery results with special emphasis on use of a scoring scale. Am J Sports Med 1982; 10 (3) 150-154
• 24 Tegner Y, Lysholm J. Rating systems in the evaluation of knee ligament injuries. Clin Orthop Relat Res 1985; (198) 43-49
• 25 Kon E, Filardo G, Delcogliano M , et al. Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee. Injury 2009; 40 (6) 598-603
• 26 Hefti F, Müller W, Jakob RP, Stäubli HU. Evaluation of knee ligament injuries with the IKDC form. Knee Surg Sports Traumatol Arthrosc 1993; 1 (3-4) 226-234
• 27 Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15 (12) 1833-1840
• 28 Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)—development of a self-administered outcome measure. J Orthop Sports Phys Ther 1998; 28 (2) 88-96
• 29 Dragoo JL, Wasterlain AS, Braun HJ, Nead KT. Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial. Am J Sports Med 2014; 42 (3) 610-618
• 30 Visentini PJ, Khan KM, Cook JL, Kiss ZS, Harcourt PR, Wark JD. Victorian Institute of Sport Tendon Study Group. The VISA score: an index of severity of symptoms in patients with jumper's knee (patellar tendinosis). J Sci Med Sport 1998; 1 (1) 22-28
• 31 Crossley KM, Bennell KL, Cowan SM, Green S. Analysis of outcome measures for persons with patellofemoral pain: which are reliable and valid?. Arch Phys Med Rehabil 2004; 85 (5) 815-822
• 32 James SL, Ali K, Pocock C , et al. Ultrasound guided dry needling and autologous blood injection for patellar tendinosis. Br J Sports Med 2007; 41 (8) 518-521 , discussion 522
• 33 Filardo G, Kon E, Roffi A, Di Matteo B, Merli ML, Marcacci M. Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration. Knee Surg Sports Traumatol Arthrosc 2013; ; November 26 (Epub ahead of print)
• 34 Vetrano M, Castorina A, Vulpiani MC, Baldini R, Pavan A, Ferretti A. Platelet-rich plasma versus focused shock waves in the treatment of jumper's knee in athletes. Am J Sports Med 2013; 41 (4) 795-803
• 35 Kon E, Mandelbaum B, Buda R , et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy 2011; 27 (11) 1490-1501
• 36 Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 2013; 41 (2) 356-364
• 37 Saw KY, Anz A, Siew-Yoke Jee C , et al. Articular cartilage regeneration with autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial. Arthroscopy 2013; 29 (4) 684-694
• 38 Orrego M, Larrain C, Rosales J , et al. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy 2008; 24 (12) 1373-1380
• 39 Ventura A, Terzaghi C, Borgo E, Verdoia C, Gallazzi M, Failoni S. Use of growth factors in ACL surgery: preliminary study. J Orthop Traumatol 2005; 6 (2) 76-79
• 40 Nin JR, Gasque GM, Azcárate AV, Beola JD, Gonzalez MH. Has platelet-rich plasma any role in anterior cruciate ligament allograft healing?. Arthroscopy 2009; 25 (11) 1206-1213
• 41 Sánchez M, Anitua E, Azofra J, Prado R, Muruzabal F, Andia I. Ligamentization of tendon grafts treated with an endogenous preparation rich in growth factors: gross morphology and histology. Arthroscopy 2010; 26 (4) 470-480
• 42 Saw KY, Anz A, Merican S , et al. Articular cartilage regeneration with autologous peripheral blood progenitor cells and hyaluronic acid after arthroscopic subchondral drilling: a report of 5 cases with histology. Arthroscopy 2011; 27 (4) 493-506
• 43 Kellgren JH, Jeffrey M, Ball J. Atlas of Standard Radiographs. Vol. 2. Oxford: Blackwell Scientific; 1963
• 44 Riddle DL, Jiranek WA, Hull JR. Validity and reliability of radiographic knee osteoarthritis measures by arthroplasty surgeons. Orthopedics 2013; 36 (1) e25-e32
• 45 Kumar KA, Rao JB, Pavan Kumar B, Mohan AP, Patil K, Parimala K. A prospective study involving the use of platelet rich plasma in enhancing the uptake of bone grafts in the oral and maxillofacial region. J Maxillofac Oral Surg 2013; 12 (4) 387-394
• 46 Figueroa D, Melean P, Calvo R , et al. Magnetic resonance imaging evaluation of the integration and maturation of semitendinosus-gracilis graft in anterior cruciate ligament reconstruction using autologous platelet concentrate. Arthroscopy 2010; 26 (10) 1318-1325
• 47 Radice F, Yánez R, Gutiérrez V, Rosales J, Pinedo M, Coda S. Comparison of magnetic resonance imaging findings in anterior cruciate ligament grafts with and without autologous platelet-derived growth factors. Arthroscopy 2010; 26 (1) 50-57
• 48 Silva A, Sampaio R, Pinto E. Femoral tunnel enlargement after anatomic ACL reconstruction: a biological problem?. Knee Surg Sports Traumatol Arthrosc 2010; 18 (9) 1189-1194
• 49 Vavken P, Sadoghi P, Murray MM. The effect of platelet concentrates on graft maturation and graft-bone interface healing in anterior cruciate ligament reconstruction in human patients: a systematic review of controlled trials. Arthroscopy 2011; 27 (11) 1573-1583
• 50 Vogrin M, Rupreht M, Dinevski D , et al. Effects of a platelet gel on early graft revascularization after anterior cruciate ligament reconstruction: a prospective, randomized, double-blind, clinical trial. Eur Surg Res 2010; 45 (2) 77-85
• 51 Mosher TJ, Walker EA, Petscavage-Thomas J, Guermazi A. Osteoarthritis year 2013 in review: imaging. Osteoarthritis Cartilage 2013; 21 (10) 1425-1435
• 52 Wasterlain AS, Braun HJ, Harris AH, Kim HJ, Dragoo JL. The systemic effects of platelet-rich plasma injection. Am J Sports Med 2013; 41 (1) 186-193
• 53 Walters SJ. Consultants' forum: should post hoc sample size calculations be done?. Pharm Stat 2009; 8 (2) 163-169
• 54 Higgins JP, Altman DG, Gøtzsche PC , et al; Cochrane Bias Methods Group. Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928
• 55 Dragoo JL, Braun HJ, Durham JL , et al. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med 2012; 40 (6) 1274-1281